Stevanato Group S.p.a. revenue

Stevanato Group S.p.a.'s revenue was $1.34bn in fiscal 2025, up 12.3% on the year before. Since fiscal 2019 ($601m) it has grown at a compound 14.3% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Stevanato Group S.p.a.: revenue history, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	601	755	998	1,036	1,174	1,195	1,341
Growth on the year before	—	+25.8%	+32.2%	+3.8%	+13.3%	+1.8%	+12.3%
Gross profit	155	222	314	337	368	327	389
Gross margin	25.7%	29.3%	31.4%	32.5%	31.3%	27.4%	29.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Stevanato Group S.p.a.	$1.34bn	12.3%	—
Haemonetics Corp	$1.35bn	0.4%	3.5%
Penumbra Inc	$1.56bn	17.0%	16.2%
Merit Medical Systems Inc	$1.61bn	9.1%	9.5%
Integra Lifesciences Holdings Corp	$1.66bn	0.8%	2.4%
Tandem Diabetes Care Inc	$1.04bn	4.0%	9.6%

Compare with peers

Head to head: HAE vs STVN PEN vs STVN MMSI vs STVN

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Stevanato Group S.p.a.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Stevanato Group S.p.a.